Zobrazeno 1 - 9
of 9
pro vyhledávání: '"AKIYO HORI"'
Autor:
Kazuhide Tanaka, Akiyo Hori, Tomoya Tachi, Tomohiro Osawa, Katsuhiro Nagaya, Teppei Makino, Seiji Inoue, Masahiro Yasuda, Takashi Mizui, Takumi Nakada, Chitoshi Goto, Hitomi Teramachi
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 4, Iss 1, Pp 1-14 (2018)
Abstract Background In recent years, cancer chemotherapy is being conducted at outpatient clinics, wherein pharmacists are involved with patient guidance and management of adverse events as experts in medication therapy. Therefore, we clarified the i
Externí odkaz:
https://doaj.org/article/0d8491c5075c4372bab932bca4a07d31
Autor:
Emiri Matsumiya, Haruka Sahashi, Hisao Komeda, Akiyo Hori, Sora Sano, Midori Soda, Kiyoyuki Kitaichi, Akari Asano, Chitoshi Goto, Takashi Mizui, Maho Ariga
Publikováno v:
Anticancer Research. 40:7101-7108
Background/aim It has been reported that some adverse events (AEs) of enzalutamide (ENZ) occur more frequently in Japanese patients with castration-resistant prostate cancer (CRPC) due to higher steady-state trough plasma concentrations of ENZ (CSS,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da0965323283cf6b5d8b047b19a4126a
https://doi.org/10.21873/anticanres.14739
https://doi.org/10.21873/anticanres.14739
Autor:
Akari Asano, Kiyoyuki Kitaichi, Midori Soda, Shigeyuki Usui, Sora Sano, Akiyo Hori, Haruka Sahashi, Maho Ariga, Emiri Matsumiya, Chitoshi Goto
Publikováno v:
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 46:257-265
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa0b7cca4337d68443e4c034a46db4a8
https://doi.org/10.5649/jjphcs.46.257
https://doi.org/10.5649/jjphcs.46.257
Autor:
YUNA SADAKA, MIDORI SODA, AKIYO HORI, YURI MIYAHARA, YASUHISA OIDA, YOICHI NISHIGAKI, EIICHI TOMITA, TAKASHI MIZUI, KIYOYUKI KITAICHI
Publikováno v:
Anticancer research. 42(4)
The antiviral agent ritonavir is a substrate for cytochrome P450 3A4 (CYP3A4); therefore, concomitant use of CYP3A4-metabolising drugs might cause adverse reactions to this drug. We investigated the plasma level of calcium channel blockers (CCBs) as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e461047dd3ec246ac9c9199db00c5ed2
https://pubmed.ncbi.nlm.nih.gov/35347032
https://pubmed.ncbi.nlm.nih.gov/35347032
Autor:
Teppei Makino, Takashi Mizui, Tomohiro Osawa, Masahiro Yasuda, Kazuhide Tanaka, Akiyo Hori, Katsuhiro Nagaya, Tomoya Tachi, Takumi Nakada, Hitomi Teramachi, Seiji Inoue, Chitoshi Goto
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 4, Iss 1, Pp 1-14 (2018)
Journal of Pharmaceutical Health Care and Sciences
Journal of Pharmaceutical Health Care and Sciences
Background In recent years, cancer chemotherapy is being conducted at outpatient clinics, wherein pharmacists are involved with patient guidance and management of adverse events as experts in medication therapy. Therefore, we clarified the influence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9a602ca60593362e9e819188a5543e8
http://link.springer.com/article/10.1186/s40780-018-0105-3
http://link.springer.com/article/10.1186/s40780-018-0105-3
Autor:
Chitoshi Goto, Midori Soda, Yoichi Nishigaki, Yuka Asama, Takashi Mizui, Eiichi Tomita, Kiyoyuki Kitaichi, Yuna Sadaka, Akiyo Hori, Akiko Kwaji
Publikováno v:
Proceedings for Annual Meeting of The Japanese Pharmacological Society. :PO3-9
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4a2cd058a8b920016652947c21855741
https://doi.org/10.1254/jpssuppl.wcp2018.0_po3-9-7
https://doi.org/10.1254/jpssuppl.wcp2018.0_po3-9-7
Autor:
Tomohiro, Osawa, Seiji, Inoue, Michi, Umeda, Takaaki, Hasegawa, Teppei, Makino, Akiyo, Hori, Kazuhide, Tanaka, Masahiro, Yasuda, Takashi, Mizui, Toshiyuki, Sawa, Yasuyuki, Sugiyama, Chitoshi, Goto
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 45(10)
Skin reactions to nivolumab are typical immune-related adverse events. We investigated the relation between patient background and test values before nivolumab administration and skin reactions. From February 2016 to February 2017, we evaluated the c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6b526d2fbcbe988a040dd0b76219e46c
https://pubmed.ncbi.nlm.nih.gov/30382069
https://pubmed.ncbi.nlm.nih.gov/30382069
Autor:
Teppei Makino, Tomohiro Osawa, Chitoshi Goto, Takumi Nakada, Kazuhide Tanaka, Akiyo Hori, Katsuhiro Nagaya, Takashi Mizui, Masahiro Yasuda
Publikováno v:
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 42:727-737
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5efe54ef27b180c321af625e51a52cde
https://doi.org/10.5649/jjphcs.42.727
https://doi.org/10.5649/jjphcs.42.727
Autor:
Tomoya Tachi, Takashi Mizui, Tomohiro Osawa, Kazuhide Tanaka, Teruo Tsuchiya, Hitomi Teramachi, Chitoshi Goto, Shoko Asano, Takumi Nakada, Yoshihiro Noguchi, Masahiro Yasuda, Akiyo Hori, Azusa Kawashima
Publikováno v:
SpringerPlus
In the field of occupational health services, productivity loss can be expressed by absenteeism (i.e., employees being absent from work and taking leave due to health problems) and presenteeism (i.e., a reduction in the ability to perform one’s tas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0a2bea3b6bc24cd82d318e0780805ac
https://doi.org/10.1186/s40064-016-1979-x
https://doi.org/10.1186/s40064-016-1979-x